Search results
Results From The WOW.Com Content Network
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The ...
The Philippine Genome Center was established as a collaboration between the University of the Philippines and the Department of Science and Technology (DOST). [1] It was first conceptualized in 2009 in response to the SARS outbreak which affected Hong Kong, the dengue outbreaks which affecting the Philippines, and the then-ongoing H1N1 flu pandemic which originated in Mexico.
This list is based on the Forbes Global 2000, which ranks the world's 2,000 largest publicly traded companies.The Forbes list takes into account a multitude of factors, including the revenue, net profit, total assets and market value of each company; each factor is given a weighted rank in terms of importance when considering the overall ranking.
The NITL is the diagnostic center for the rapid detection of mycotoxins and plant, food, and feed pathogens. The laboratory can determine the concentrations of the mycotoxins, aflatoxin B1 and M1, ochratoxin A, zearalenone, fumonisin and red tide toxins to as low as 5 ppb.
Cepheid [a] is an American molecular diagnostics company that is a wholly owned subsidiary of Danaher Corporation. Its systems automate traditional nucleic acid tests (tests for specific sequences of DNA or RNA). The tests can be used to identify and analyze pathogens and genetic disorders.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
[2]: ch 37 In 2012, molecular diagnostic techniques for Thalassemia use genetic hybridization tests to identify the specific single nucleotide polymorphism causing an individual's disease. [11] As the commercial application of molecular diagnostics has become more important, so has the debate about patenting of the genetic discoveries at its heart.
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. [3]On May 8, 2020 the U.S. Food and Drug Administration (FDA) issued to Quidel the first emergency use authorization (EUA) for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic.